Profile
Andrew D.
Reddick served as President, CEO & Independent Director at Acura Pharmaceuticals, Inc. from 2011 to 2011.
Prior to that, he was the Chief Operating Officer & SVP-Commercial Operation at Adolor Corp.
in 2002, President at Alpharma Pharmaceuticals LLC in 1999 to 2000, and EVP-Marketing, Sales & Business Development at Purepac Pharmaceutical Co. from 1996 to 1999.
Reddick holds an MBA from Duke University and an undergraduate degree from the University of California, Berkeley.
Former positions of Andrew D. Reddick
| Companies | Position | End |
|---|---|---|
| ACURA PHARMACEUTICALS, INC. | President | 27/04/2011 |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Chief Operating Officer | 31/08/2002 |
Alpharma Pharmaceuticals LLC
 Alpharma Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Alpharma Pharmaceuticals LLC is a pharmaceutical company that manufactures pharmaceuticals. The company is based in Raleigh, NC. | President | 29/02/2000 |
Purepac Pharmaceutical Co.
 Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Sales & Marketing | 31/05/1999 |
Training of Andrew D. Reddick
| Duke University | Masters Business Admin |
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACURA PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
Alpharma Pharmaceuticals LLC
Alpharma Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Alpharma Pharmaceuticals LLC is a pharmaceutical company that manufactures pharmaceuticals. The company is based in Raleigh, NC. | Health Technology |
Purepac Pharmaceutical Co.
Purepac Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Purepac Pharmaceutical Co. a subsidiary of Actavis Group Hf. Alpharma U.S. Human Pharmaceuticals and Purepac Pharmaceuticals have now become Actavis Group Hf. Purepac Pharmaceuticals manufactures generic equivalent drugs for cardiovascular, inflammatory, and central nervous system disorders. The company was headquartered in Elizabeth, NJ. | Health Technology |
- Stock Market
- Insiders
- Andrew D. Reddick
